Mary Bartlett Bunge (1931 – 2024) was a foundational figure in modern neuroscience, specifically in the field of spinal cord injury and repair. For over six decades, her research challenged the long-held dogma that the central nervous system was incapable of regeneration. Through her pioneering work with Schwann cells and her leadership at the University of Miami, she paved the way for contemporary clinical trials that offer hope to those living with paralysis.
1. Biography: Early Life and Academic Trajectory
Mary Bartlett was born on April 3, 1931, in New Haven, Connecticut. Her journey into the biological sciences began at Simmons College in Boston, where she earned her B.S. in Biology in 1953. She then moved to the University of Wisconsin-Madison, obtaining her M.S. (1955) and her Ph.D. (1960) in Zoology.
It was at Wisconsin that she met her lifelong partner and collaborator, Richard Bunge. The two married in 1955, forming one of the most productive scientific "power couples" in history. Their career trajectory saw them move through several prestigious institutions:
- Columbia University (1960–1970): Where they conducted groundbreaking electron microscopy studies.
- Washington University in St. Louis (1970–1988): Where they established a world-class laboratory focused on cell biology and nerve regeneration.
- University of Miami Miller School of Medicine (1988–2024): The Bunges were recruited to join The Miami Project to Cure Paralysis. Mary served as the Christine E. Lynn Distinguished Professor of Neuroscience and remained active in research and mentorship until her passing in February 2024.
2. Major Contributions: The Schwann Cell Pioneer
Mary Bunge’s work focused on the Schwann cell, the principal glia of the peripheral nervous system (PNS). Her major contributions redefined how scientists view the environment of the spinal cord:
- Discovery of Remyelination: In the early 1960s, using electron microscopy, she was among the first to demonstrate that the central nervous system (CNS) could undergo remyelination (the repair of the protective myelin sheath around nerves). This proved that the damage from diseases like Multiple Sclerosis or traumatic injury was not necessarily permanent.
- The "Bunge Bridge": She developed a revolutionary methodology using Schwann cells to create a "bridge" across a spinal cord injury site. Her research showed that these cells could support and guide regrowing axons (nerve fibers) across the scar tissue that typically blocks recovery.
- Extracellular Matrix (ECM) Interactions: She conducted seminal research on how Schwann cells interact with the extracellular environment to promote nerve growth, emphasizing that the "soil" of the nervous system is just as important as the "seed" (the neuron).
- Combination Therapies: Recognizing that a single "magic bullet" was unlikely to cure paralysis, Bunge pioneered combination strategies—pairing Schwann cell grafts with signaling molecules (like cyclic AMP) and enzymes (like chondroitinase) to overcome the inhibitory environment of the injured cord.
3. Notable Publications
Bunge authored over 160 scientific papers, many of which are considered foundational to the field of neurobiology.
- "Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord" (1961): Published in the Journal of Biophysical and Biochemical Cytology, this was a landmark study proving that the CNS could repair its myelin.
- "The biology of demyelination and remyelination" (1968): A definitive early text on the pathology of nerve insulation.
- "Functional reorganization of the rat spinal cord by transplantation of Schwann cells" (1990s-2000s): A series of papers in the Journal of Neuroscience that detailed the "bridge" technique and laid the groundwork for human trials.
- "Combination strategies to improve regeneration across and beyond a Schwann cell graft" (2006): A key paper in Experimental Neurology discussing the multi-faceted approach to spinal cord repair.
4. Awards & Recognition
Bunge’s contributions were recognized by the highest echelons of the scientific community:
- National Academy of Medicine: Elected as a member in 2005 (then the Institute of Medicine).
- Mika Salpeter Lifetime Achievement Award (2012): Awarded by the Society for Neuroscience for her excellence in research and her role in advancing women in the field.
- Christopher Reeve Research Medal (2001): For her outstanding contributions to spinal cord repair.
- Friedrich von Recklinghausen Award (1998): For her research on neurofibromatosis and Schwann cell biology.
- Honorary Doctorates: Including a notable degree from her alma mater, Simmons College.
5. Impact & Legacy
Mary Bunge’s legacy is twofold: scientific and cultural.
Scientific Impact
Her decades of basic research culminated in 2012 when the FDA approved the first Phase 1 clinical trial to transplant a patient’s own Schwann cells into their injured spinal cord. This was a direct translation of the "Bunge Bridge" from the lab bench to the human bedside.
Cultural Impact
As a woman entering science in the 1950s, Bunge was a trailblazer. She was a tireless mentor who advocated for women in neuroscience, often hosting students in her home and ensuring that young researchers received credit for their work. She proved that a collaborative, partnership-based model of research (working alongside her husband) could produce world-changing results.
6. Collaborations
- Richard Bunge: Her husband was her primary collaborator until his death in 1996. Together, they were the "heart and soul" of spinal cord research for decades.
- The Miami Project to Cure Paralysis: She worked closely with co-founder Nick Buoniconti and researchers like W. Dalton Dietrich and Patrick Wood.
- The NIH and NINDS: Bunge was a frequent collaborator and advisor for the National Institutes of Health, shaping the federal funding landscape for spinal cord injury research.
7. Lesser-Known Facts
- Longevity in the Lab: Mary Bunge did not believe in "retirement" in the traditional sense. She remained an active, grant-funded researcher well into her 90s, continuing to publish and mentor until shortly before her death at age 92.
- Artistic Eye: Her mastery of electron microscopy was not just scientific; it was aesthetic. Her early images of the "nodes of Ranvier" and myelin sheaths were often described as beautiful, resembling abstract art, and helped a generation of scientists "see" the nervous system for the first time.
- Overcoming Tragedy: After her husband Richard died in 1996, many expected Mary to step back from the lab. Instead, she redoubled her efforts, taking over the leadership of their shared projects and pushing their research into the clinical trial phase—a testament to her resilience and dedication to their shared vision.